0001209191-20-004492.txt : 20200122
0001209191-20-004492.hdr.sgml : 20200122
20200122164420
ACCESSION NUMBER: 0001209191-20-004492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200117
FILED AS OF DATE: 20200122
DATE AS OF CHANGE: 20200122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trower Paul
CENTRAL INDEX KEY: 0001642041
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 20539355
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-17
0
0000879169
INCYTE CORP
INCY
0001642041
Trower Paul
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
Principal Accounting Officer
Common Stock
2020-01-17
4
A
0
4018
0.00
A
21324
D
Employee Stock Option (right to buy)
80.50
2020-01-17
4
A
0
2290
0.00
A
2030-01-16
Common Stock
2290
2290
D
Represents award of restricted stock units ("RSUs") that will vest 100% on the fourth anniversary of the grant date of January 17, 2020, subject to Paul Trower's continued service with the Issuer through the applicable vesting date. The RSUs may be settled only for shares of common stock on a one-for-one basis.
Including the January 17, 2020 Restricted Stock Unit Grant, this includes an aggregate of 11,011 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Beginning January 17, 2020, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2020 and the remainder vesting monthly over three years.
/s/ Paul Trower
2020-01-22